JVM Co

JVM Co Assets per Share

The Total Assets per Share of JVM Co (054950.KQ) as of Nov 4, 2026 is 27,706.87 KRW. In the previous year, Total Assets per Share was 24,726.50 KRW — a change of 12.05% (higher).

Assets per Share

27,706.87KRW

YoY

12.05%

Last updated:

Total Assets per Share of JVM Co is 2025 27,706.87 KRW. Total Assets per Share of JVM Co was 2024 24,726.50 KRW. It decreases by 12.05% higher compared to the previous year.

The JVM Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
15,344.43 KRW
Jan 1, 2019
15,637.49 KRW
Jan 1, 2020
17,358.17 KRW
Jan 1, 2021
18,322.65 KRW
Jan 1, 2022
20,117.51 KRW
Jan 1, 2023
22,358.27 KRW
Jan 1, 2024
24,726.50 KRW
Jan 1, 2025
27,706.87 KRW
The JVM Co Assets per Share history
YEARAssets per ShareYoY
27,706.87KRW+12.05%
24,726.50KRW+10.59%
22,358.27KRW+11.14%
20,117.51KRW+9.80%
18,322.65KRW+5.56%
17,358.17KRW+11.00%
15,637.49KRW+1.91%
15,344.43KRW+2.50%
14,969.80KRW-2.38%
15,334.35KRW+8.81%
14,093.42KRW-4.50%
14,757.67KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Total Assets per Share of JVM Co is 27,706.87 KRW in 2025.

Total Assets per Share of JVM Co changed from 24,726.50 KRW to 27,706.87 KRW, representing a 12.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share JVM Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — JVM Co

All Key Metrics — JVM Co